methylprednisolone has been researched along with Endometrial Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bando, T; Heike, Y; Ishikawa, Y; Ito, R; Kojima, F; Koyamada, R; Kurihara, Y; Mori, S; Morimoto, M; Myojo, T; Tada, K; Yamashita, T; Yoshiyasu, N | 1 |
| Bagaméri, A; Lehoczky, O; Pulay, T; Udvary, J | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Efstathiou, E; Galani, E; Kastritis, E; Papadimitriou, C; Zorzou, MP | 1 |
| Adamus, G; Amundson, D; Gouras, P; MacKay, C | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
2 trial(s) available for methylprednisolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients--a randomized study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Endometrial Neoplasms; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Ovarian Neoplasms; Prospective Studies; Treatment Outcome; Vomiting | 2004 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
3 other study(ies) available for methylprednisolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Case report of nivolumab-related pneumonitis.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Drug-Related Side Effects and Adverse Reactions; Endometrial Neoplasms; Female; Humans; Immunotherapy; Lung; Lymphocytes; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Nivolumab; Pneumonia; Programmed Cell Death 1 Receptor; Tomography, X-Ray Computed | 2017 |
Carboplatin hypersensitivity reactions: a single institution experience.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Dexamethasone; Drug Hypersensitivity; Endometrial Neoplasms; Female; Histamine H1 Antagonists; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Urinary Bladder Neoplasms | 2005 |
Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
Topics: Adjuvants, Immunologic; Amino Acids; Antibodies, Neoplasm; Antigens, Neoplasm; Autoantibodies; Biomarkers, Tumor; Calcium-Binding Proteins; Carbohydrates; Combined Modality Therapy; Drug Combinations; Endometrial Neoplasms; Eye Proteins; Female; Glucocorticoids; Hippocalcin; Humans; Humic Substances; Lipoproteins; Methylprednisolone; Middle Aged; Nerve Tissue Proteins; Paraneoplastic Syndromes; Recoverin; Retinal Diseases; T-Lymphocytes; Uronic Acids | 1998 |